Results 231 to 240 of about 16,333 (257)

Direct-acting antiviral treatment for hepatitis C

The Lancet, 2019
Jacinta A, Holmes, Stephanie M, Rutledge, Raymond T, Chung   +2 more
openaire   +2 more sources

Treatment as prevention effect of direct-acting antivirals on primary hepatitis C virus incidence: findings from a multinational cohort between 2010 and 2019

EClinicalMedicine, 2023
Andrí Rauch, Juan Berenguer, Inma Jarrin   +2 more
exaly  

Direct-acting antiviral agents

Reactions Weekly, 2019
openaire   +1 more source

Pangenotypic direct acting antivirals for the treatment of chronic hepatitis C virus infection: A systematic literature review and meta-analysis

EClinicalMedicine, 2020
Rita Morassut, Roger Chou, Ayesha Siddiqua   +2 more
exaly  

Incidence and Risk Factors of Hepatocellular Carcinoma in Patients with Chronic Hepatitis C Treated with Direct-Acting Antivirals

Viruses, 2023
Carmem Theodoro, Solange Artimos De Oliveira, Renata Perez   +2 more
exaly  

A Systematic Review of Direct-Acting Antivirals for Hepatitis C in Advanced CKD

Kidney International Reports, 2023
Michel Jadoul, Paul Martin, Gaelen P Adam   +2 more
exaly  

Hepatitis C Clearance by Direct-Acting Antivirals Impacts Glucose and Lipid Homeostasis

Journal of Clinical Medicine, 2020
Thierry Poynard, Alica Kubesch, Jörg Bojunga   +2 more
exaly  

Treatment of chronic hepatitis C-associated cryoglobulinemia vasculitis at the era of direct-acting antivirals

Therapeutic Advances in Gastroenterology, 2020
Cloe Comarmond, Patrice Cacoub, David Saadoun   +2 more
exaly  

Direct-acting Antivirals for Hepatitis C and Implication for Community Pharmacy Practice

Current Pharmaceutical Design, 2023
Yifei Liu
exaly  

Risk of Hepatocellular Carcinoma after HCV Clearance by Direct-Acting Antivirals Treatment Predictive Factors and Role of Epigenetics

Cancers, 2020
Luigi Elio Adinolfi, Giusy Corvino, Luca Rinaldi   +2 more
exaly